| abstract |
here are provided il-21 muteins and fusion proteins comprising them for use in methods of treating a disease. conjugates, nucleic acids, vectors, host cells, pharmaceutical compositions and related kits are also provided here. methods of preparing the il-21 muteins and fusion proteins comprising them, as well as methods of treating a subject in need, are provided by the present disclosure. pd-1 antigen binding proteins are additionally provided. |